Your browser doesn't support javascript.
loading
Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma.
Saberian, Chantal; Amaria, Rodabe N; Najjar, Amer M; Radvanyi, Laszlo G; Haymaker, Cara L; Forget, Marie-Andrée; Bassett, Roland L; Faria, Silvana C; Glitza, Isabella C; Alvarez, Enrique; Parshottam, Sapna; Prieto, Victor; Lizée, Gregory; Wong, Michael K; McQuade, Jennifer L; Diab, Adi; Yee, Cassian; Tawbi, Hussein A; Patel, Sapna; Shpall, Elizabeth J; Davies, Michael A; Hwu, Patrick; Bernatchez, Chantale.
Afiliação
  • Saberian C; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Amaria RN; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Najjar AM; Department of Pediatrics - Research, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Radvanyi LG; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Haymaker CL; Ontario Institute for Cancer Research, Ontario, Ontario, Canada.
  • Forget MA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, Houston, TX, USA.
  • Bassett RL; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Faria SC; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Glitza IC; Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Alvarez E; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Parshottam S; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Prieto V; Department of Biologics Development, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Lizée G; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wong MK; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • McQuade JL; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Diab A; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Yee C; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Tawbi HA; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Patel S; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Shpall EJ; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Davies MA; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Hwu P; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Bernatchez C; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA cbernatchez@mdanderson.org Patrick.Hwu@moffitt.org.
J Immunother Cancer ; 9(5)2021 05.
Article em En | MEDLINE | ID: mdl-34021033

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Células Dendríticas / Linfócitos T / Imunoterapia Adotiva / Linfócitos do Interstício Tumoral / Depleção Linfocítica / Vacinas Anticâncer / Melanoma Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Células Dendríticas / Linfócitos T / Imunoterapia Adotiva / Linfócitos do Interstício Tumoral / Depleção Linfocítica / Vacinas Anticâncer / Melanoma Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article